284 related articles for article (PubMed ID: 23030423)
21. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
[TBL] [Abstract][Full Text] [Related]
23. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
Moor CT; Roberts SA; Simmons G; Briggs S; Morris AJ; Smith J; Heffernan H
J Hosp Infect; 2008 Apr; 68(4):355-62. PubMed ID: 18353497
[TBL] [Abstract][Full Text] [Related]
24. [Bacteraemia due to extended-spectrum beta-lactamases (ESBL) and other beta-lactamases (ampC and carbapenemase) producing Enterobacteriaceae: association with health-care and cancer].
García-Gómez M; Guío L; Hernández JL; Vilar B; Pijoán JI; Montejo JM
Rev Esp Quimioter; 2015 Oct; 28(5):256-62. PubMed ID: 26437756
[TBL] [Abstract][Full Text] [Related]
25. Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum β-lactamase (ESBL) and non-ESBL producing Escherichia coli.
Hsieh CJ; Shen YH; Hwang KP
J Microbiol Immunol Infect; 2010 Jun; 43(3):240-8. PubMed ID: 21291853
[TBL] [Abstract][Full Text] [Related]
26. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
28. [Frequency and risk factors for bacteremia caused by extendedspectrum beta-lactamase-producing enterobacteriaceae in patients of a public hospital in Lima, Peru].
Sarmiento AF; Mejia MN; Rozas AB; Giraldo CA; Málaga G
Rev Peru Med Exp Salud Publica; 2018; 35(1):62-67. PubMed ID: 29924279
[TBL] [Abstract][Full Text] [Related]
29. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
[TBL] [Abstract][Full Text] [Related]
30. Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards.
Dolejska M; Brhelova E; Dobiasova H; Krivdova J; Jurankova J; Sevcikova A; Dubska L; Literak I; Cizek A; Vavrina M; Kutnikova L; Sterba J
Int J Antimicrob Agents; 2012 Dec; 40(6):510-5. PubMed ID: 23043911
[TBL] [Abstract][Full Text] [Related]
31. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
32. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
[TBL] [Abstract][Full Text] [Related]
33. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
34. A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department users.
Lee CH; Chu FY; Hsieh CC; Hong MY; Chi CH; Ko WC; Lee CC
Medicine (Baltimore); 2017 Apr; 96(16):e6648. PubMed ID: 28422867
[TBL] [Abstract][Full Text] [Related]
35. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae in Trakya University Hospital, Turkey.
Akata F; Tatman-Otkun M; Ozkan E; Tansel O; Otkun M; Tugrul M
New Microbiol; 2003 Jul; 26(3):257-62. PubMed ID: 12901421
[TBL] [Abstract][Full Text] [Related]
39. Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
Prinapori R; Guinaud J; Khalil A; Lecuyer H; Gendrel D; Lortholary O; Nassif X; Viscoli C; Zahar JR
Am J Infect Control; 2013 Mar; 41(3):259-60. PubMed ID: 23062579
[TBL] [Abstract][Full Text] [Related]
40. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
Sfeir MM; Askin G; Christos P
Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
